Categories: AlphaGraphs

DKS Earnings: Highlights of DICK’S Sporting Goods’ Q3 2025 report

Sportswear company DICK’S Sporting Goods, Inc. (NYSE: DKS) on Tuesday reported a decrease in adjusted earnings for the third quarter of fiscal 2025, despite a year-over-year increase in sales.

DICK’s reported net income of $75 million or $0.86 per share in the third quarter, compared to $228 million or $2.75 per share in the year-ago quarter. Adjusted earnings were $2.07 per share, vs. $2.75 per share last year. Meanwhile, net sales jumped 36% year-over-year to $4.2 billion in the October quarter. Comparable store sales rose 5.7% in Q3.

The company raised its full-year 2025 guidance for comparable sales growth to a range of 3.5% to 4% from the earlier forecast of a 2-3.5% growth. It also increased full-year earnings per share guidance to a range of $14.25 to $14.55 from the previous outlook of $13.90-14.50.

“The effectiveness of our long-term strategies and the best-in-class execution by our team are driving outstanding results for our DICK’S Business. In the third quarter, the DICK’S Business comps grew 5.7%, driven by increases in both average ticket and transactions, and we were pleased to deliver gross margin expansion,” said Lauren Hobart, CEO of DICK’s Sporting.

Recent Posts

S&P Global (SPGI) reports double-digit growth in Q4 adj. earnings; revenue up 9%

S&P Global (NYSE: SPGI), a leading provider of financial intelligence solutions, reported strong earnings growth…

8 minutes ago

Fiserv (FISV) Earnings: 4Q25 Key Numbers

Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…

22 minutes ago

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

24 minutes ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

47 minutes ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

1 hour ago

DuPont Reports 2025 Full-Year Results and Issues 2026 Guidance Following Strategic Spinoffs

The industrial materials manufacturer reported flat fourth-quarter sales and a full-year organic growth rate of…

1 hour ago